Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04890652 · ClinicalTrials.gov registry record · NA

Digital Interventions to Treat Hazardous Drinking

A NA study of Stress and Hazardous Drinking, sponsored by Yale University.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT04890652 is a NA study of Stress and Hazardous Drinking that has completed, run by Yale University. The registered enrollment target is 33 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04890652, a NA study of Stress and Hazardous Drinking, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

There has been a significant increase in the prevalence of stress- and alcohol- related disorders during the COVID-19 pandemic. This project aims to conduct a feasibility study to evaluate the preliminary efficacy of a digital intervention designed to reduce stress and alcohol use. Additionally, this study will examine the impact of stress, including COVID-19 related stress, on the risk of alcohol misuse and the outcomes of the intervention in risky social drinkers.

Interventions

  • BEHAVIORAL Digital intervention

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2021-10-13
Est. Completion 2023-08-23
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04890652

The ClinicalTrials.gov registry entry for NCT04890652 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 152 other Stress trials with a reported enrollment target (96% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Digital intervention is the first listed.

NCT04890652 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04890652 about?

NCT04890652 is a clinical study titled "Digital Interventions to Treat Hazardous Drinking". There has been a significant increase in the prevalence of stress- and alcohol- related disorders during the COVID-19 pandemic. This project aims to conduct a feasibility study to evaluate the preliminary efficacy of a digital intervention designed to reduce stress and alcohol use. Additionally, thi...

What is the current status of trial NCT04890652?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-10-13. Estimated completion is 2023-08-23.

What conditions does trial NCT04890652 study?

This clinical trial studies the following conditions: Stress, Hazardous Drinking.

What interventions are being tested in trial NCT04890652?

The interventions under investigation include: Digital intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04890652?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04890652 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.